AGP Picks View all

AGP Executive Report

Last update: 4 hours ago

Long COVID Brain Scan Update: Finnish researchers report no widespread brain inflammation in people with long COVID; instead, the most severe cases show heightened activity in emotion, stress and memory-related regions. Youth Mental Health Care: A new thesis finds coercive measures are still used often in inpatient child and adolescent psychiatry, with big variation between services and no clear drop after stricter Swedish rules—comparisons include Finland. Prenatal Testing Accuracy: Case reports highlight how NIPT can miss trisomy 21 when placental mosaicism dilutes fetal DNA signals, with ultrasound findings helping flag false negatives. Hearing Loss Biomarkers: A study explores serum CAPN1 and CLEC2 as potential biomarkers for sudden sensorineural hearing loss severity and internal auditory artery narrowing. Finland Alcohol Trend: THL says recorded alcohol consumption fell again in 2025, reaching levels last seen in the 1970s. Wellness & Nutrition Innovation: Raisio secured Business Finland funding to upcycle grain processing side streams into functional fiber ingredients. Care & Pain Research: Trials and protocols cover electroacupuncture for trigeminal neuralgia, and improved pain approaches for knee osteoarthritis and surgical recovery. Public Health Policy: EU roadmap aims to phase out animal testing for chemical safety assessments while preserving safety standards.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jun. 1, 2026

SuperCom wins $1.8 million Norway monitoring contract

EIN Presswire

fallback image
May 4, 2026

Thai university approves ethics review of Maha Taksa astrology study

EIN Presswire

fallback image
May 29, 2026

Lower protein intake linked to weaker physical function in older adults

EIN Presswire

fallback image
May 27, 2026

Matas Group taps Revieve to expand AI beauty across the Nordics

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Ex-BATTLE BEAST Frontwoman NOORA LOUHIMO Crowned Winner Of Finnish Singing Competition 'Tähdet, Tähdet' After Performing 'My Heart Will Go On'

Ex-BATTLE BEAST Frontwoman NOORA LOUHIMO Crowned Winner Of Finnish Singing Competition 'Tähdet, Tähdet' After Performing 'My Heart Will Go On'

Online Health Information Seeking for Pregnancy-Related Resources and Maternal eHealth Literacy Among Women in Thailand: A Qualitative Study

Online Health Information Seeking for Pregnancy-Related Resources and Maternal eHealth Literacy Among Women in Thailand: A Qualitative Study

TyG Index is Associated with Major Adverse Cardiovascular Events in HIV-Infected Individuals with Cardiovascular Disease: A Single-Center Retrospective Cohort Study

TyG Index is Associated with Major Adverse Cardiovascular Events in HIV-Infected Individuals with Cardiovascular Disease: A Single-Center Retrospective Cohort Study

The Clinical Significance of Key Pelvic Floor Ultrasound Indicators in POP Management: A Retrospective Study of Diagnostic Accuracy and Therapeutic Intervention

The Clinical Significance of Key Pelvic Floor Ultrasound Indicators in POP Management: A Retrospective Study of Diagnostic Accuracy and Therapeutic Intervention


fallback image
Jun. 1, 2026

Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases

GlobeNewswire, Inc.

fallback image
May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

GlobeNewswire, Inc.

fallback image
13 hours ago

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

GlobeNewswire, Inc.

fallback image
May 26, 2026

Public Health Command Europe Hosts 71st International Military Veterinary Exchange

DVIDS - Georgia

fallback image
May 21, 2026

Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting

GlobeNewswire, Inc.

fallback image
May 19, 2026

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Zelenskyy Says His Government Has Evidence That Russia Is Abducting Ukrainian Kids to Fight in War
Play
Zelenskyy Says His Government Has Evidence That Russia Is Abducting Ukrainian Kids to Fight in War
YouTube video thumbnail: Denmark Forms Center-Left Coalition Government
Play
Denmark Forms Center-Left Coalition Government
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: France and Allies Intercept Uncompliant Russian Shadow Fleet Tanker, Kremlin Calls It 'Piracy'
Play
France and Allies Intercept Uncompliant Russian Shadow Fleet Tanker, Kremlin Calls It 'Piracy'
YouTube video thumbnail: New Batch of Mandelson Files Published - How Embarrassing Is It for the Government?
Play
New Batch of Mandelson Files Published - How Embarrassing Is It for the Government?

Video Title

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.